 | This article includes a list of references, related reading, or external links, but its sources remain unclear because it lacks inline citations .(July 2020) |
The Biotech Fund Flanders (Dutch: Biotech Fonds Vlaanderen) was founded by the Flemish government in 1994 as an instrument to support the creation of new companies, explicitly in biotechnology. [1] It provides venture capital to biotech companies in Flanders (Belgium). The fund has 21.7 million euro of capital and is managed by the GIMV.
Agoria, previously known as Fabrimetal, is a Belgian employers' organization and member of the Federation of Belgian Enterprises.
The Michigan Life Sciences Corridor (MLSC) is a $1 billion biotechnology initiative in the U.S. state of Michigan.
VIB is a research institute located in Flanders, Belgium. It was founded by the Flemish government in 1995, and became a full-fledged institute on 1 January 1996. The main objective of VIB is to strengthen the excellence of Flemish life sciences research and to turn the results into new economic growth. VIB spends almost 80% of its budget on research activities, while almost 12% is spent on technology transfer activities and stimulating the creation of new businesses, in addition VIB spends approximately 2% on socio-economic activities. VIB is member of EU-LIFE, an alliance of leading life sciences research centres in Europe.
The Agency for Innovation by Science and Technology was a Flemish agency between 1991 and 2015. It was an externally autonomized agency of the Flemish Government, in charge of innovation policy in Flanders and located in the Ellipse-Building in Brussels.
Gimv (Euronext Brussels: GIMB ) is a Belgian European investment company with experience in private equity and venture capital. Gimv is listed on Euronext Brussels and manages around 1.5 billion EUR invested in about 60 portfolio companies.
CropDesign is a biotech company located in Ghent, Belgium. The company develops a portfolio of agronomic traits for the global commercial seed markets. It has developed a technology platform to discover genetic traits for the improvement of corn, rice and other plants. Current managing director is Juergen Logemann.
The National Fund for Scientific Research (NFSR) was once a government institution in Belgium for supporting scientific research until it was split into two separate organizations:
Science and technology in Flanders, being the Flemish Community and more specifically the northern region of Belgium (Europe), is well developed with the presence of several universities and research institutes. These are strongly spread over all Flemish cities, from Kortrijk and Bruges in the Western side, over Ghent as a major university center alongside Antwerp, Brussels and Leuven to Hasselt and Diepenbeek in the Eastern side.
LRG Capital Group is a global investment, banking and advisory shop that focuses on public and private companies in the technology, life sciences, hospitality, real estate and entertainment sectors. The firm was founded by Lawrence R. Goldfarb, formerly a managing director in the mergers & acquisitions group at CS First Boston.
The Participatiemaatschappij Vlaanderen (PMV) is an independent organization owned by the Flemish government which supports economic investment initiatives in Flanders.
Flanders in Action is a social and economic action programme for the future of Flanders which was established by the Flemish government on 11 July 2006.
finance&invest.brussels was founded by the Brussels-Capital Region in 1984 to provide capital to the Brussels-Capital Region industry. The purpose of finance&invest.brussels is to invest in the equity of unlisted companies.
Signature BioScience Inc. was the first biotechnology company based in San Francisco. It was formed in 1998 but closed in 2003 due to lack of funding. Before Signature was dissolved, it had just completed Phase II trials on Digitoxin, which the company was pursuing as an anti-cancer compound. However, the company's core competency was developing biotechnology tools that would be used to identify highly qualified pre-clinical leads.
Kosan Biosciences, Inc., was a pharmaceutical company which dealt with cancer therapeutics medications. The company was working on advancing two new classes of anticancer agents through clinical development: heat shock protein 90 (Hsp90) inhibitors and epothilones.
Sofinnova is the name shared by two venture capital firms, Sofinnova Partners and Sofinnova Ventures. The name Sofinnova is a contraction of the French, "Société de Financement de l’Innovation" or, Innovation Venture Capital Company. Both firms trace their roots back to Sofinnova SA, an investment institution founded in Paris in 1972. The two firms have raised ~$4B since inception and have generally shared a similar investment strategy of financing projects and ideas in the life sciences and technology sectors. The firms distinguish themselves on the basis of their target geographies, stage of investment, and sectors. They have been independent entities since 1997.
Corporate venture capital (CVC) is the investment of corporate funds directly in external startup companies. CVC is defined by the Business Dictionary as the "practice where a large firm takes an equity stake in a small but innovative or specialist firm, to which it may also provide management and marketing expertise; the objective is to gain a specific competitive advantage." Examples of CVCs include GV and Intel Capital.
Arie S. Belldegrun, FACS, is an Israeli-American urologic oncologist, billionaire businessman and investor.
Francesco De Rubertis is a partner at medicxi, a venture capital firm with offices in London, Jersey and Geneva, having co-founded the firm in February 2016. Prior to that he was a partner at another venture capital firm, Index Ventures, having led the firm's efforts to establish its life sciences practice after joining in 1997.
Greater Boston, primarily Boston and Cambridge, is home to more than 1,000 biotechnology companies, ranging from small start-ups to billion-dollar pharmaceutical companies. The many universities in the area give the region a large network of scientists.
Flagship Pioneering is an American life sciences venture capital company based in Cambridge, Massachusetts that invests in biotechnology, life sciences, health and sustainability companies. Portfolio companies include Moderna, Indigo Agriculture, Inari Agriculture and Novomer. The firm both funds and incubates companies.
 | This bank, insurance, or other financial services corporation article is a stub. You can help Wikipedia by expanding it. |
  | This Belgian company–related article is a stub. You can help Wikipedia by expanding it. |